EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model.

作者: Iranzu González , Silvestre Vicent , Enrique de Alava , Fernando Lecanda

DOI: 10.1007/S00109-007-0202-5

关键词: PhenotypeTransplantationMesenchymal stem cellFusion proteinMetastasisCell cultureBiologyCancer researchCarcinogenesisPathologySarcoma

摘要: Ewing sarcoma/primitive neuroectodermal tumors (EWS/PNET) are characterized by specific chromosomal translocations most often generating a chimeric EWS/FLI-1 gene. Depending on the number of juxtaposed exons assembled, several fusion types have been described with different incidences and prognoses. To assess impact each type phenotypic, tumorigenic, metastatic features EWS/PNET, we developed an amenable system using murine mesenchymal multipotent C3H10T1/2 cell line. Upon transduction EWS/FLI-1, cells acquired dramatic morphological changes in vitro, including smaller size "neurite-like" membrane elongations. Chimeric proteins conferred oncogenic properties anchorage-independent growth increased rate proliferation. Furthermore, expression blocked mineralization, concomitant repression osteoblastic genes, induced adipocytic differentiation program. Moreover, promoted aberrant neural phenotype de novo genes. The intramuscular injection transduced led to tumor development induction overt osteolytic lesions. Analogously, what was observed human tumors, 2 formed primary immunodeficient mice higher incidence lower latency than bearing 1 3 fusions. By contrast, expressing fusions showed activity macroscopic metastases soft tissues lesions limbs as compared type-1-expressing cells. Therefore, structure oncoprotein strongly influenced its tumorigenicity metastagenicity. Thus, this model provides basis for understanding genetic determinants involved represents cellular analyze other oncoproteins sarcomagenesis.

参考文章(53)
René Bernards, Robert A. Weinberg, A progression puzzle. Nature. ,vol. 418, pp. 823- 823 ,(2002) , 10.1038/418823A
Enrique C Torchia, Suzanne J Baker, Sobha Jaishankar, Ewing Tumor Fusion Proteins Block the Differentiation of Pluripotent Marrow Stromal Cells Cancer Research. ,vol. 63, pp. 3464- 3468 ,(2003)
Isaiah J. Fidler, The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nature Reviews Cancer. ,vol. 3, pp. 453- 458 ,(2003) , 10.1038/NRC1098
Catherine A. Reznikoff, Charles Heidelberger, David W. Brankow, John S. Bertram, Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Research. ,vol. 33, pp. 3239- 3249 ,(1973)
Shirley M. Taylor, Peter A. Jones, Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. ,vol. 17, pp. 771- 779 ,(1979) , 10.1016/0092-8674(79)90317-9
A Zoubek, B Dockhorn-Dworniczak, O Delattre, H Christiansen, F Niggli, I Gatterer-Menz, T L Smith, H Jürgens, H Gadner, H Kovar, Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor Patients Journal of Clinical Oncology. ,vol. 14, pp. 1245- 1251 ,(1996) , 10.1200/JCO.1996.14.4.1245
E de Alava, A Kawai, J H Healey, I Fligman, P A Meyers, A G Huvos, W L Gerald, S C Jhanwar, P Argani, C R Antonescu, F J Pardo-Mindan, J Ginsberg, R Womer, E R Lawlor, J Wunder, I Andrulis, P H Sorensen, F G Barr, M Ladanyi, EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. Journal of Clinical Oncology. ,vol. 16, pp. 1248- 1255 ,(1998) , 10.1200/JCO.1998.16.4.1248
Toshikazu Watsuji, Yoshichika Okamoto, Nobuhiko Emi, Yoji Katsuoka, Masatoshi Hagiwara, Controlled Gene Expression with a Reverse Tetracycline-Regulated Retroviral Vector (RTRV) System Biochemical and Biophysical Research Communications. ,vol. 234, pp. 769- 773 ,(1997) , 10.1006/BBRC.1997.6705